Le Lézard
Classified in: Health
Subjects: NPT, PER, DIS

Bello Machre Welcomes Dr. Felicia M. Jones Taylor to Board of Directors


ANNE ARUNDEL COUNTY, Md., March 25, 2025 /PRNewswire/ -- Bello Machre, a Maryland-based nonprofit dedicated to empowering individuals with developmental disabilities, is pleased to announce the appointment of Felicia M. Jones Taylor, Ed.D., to its Board of Directors.

Dr. Jones Taylor brings extensive experience in special education, nonprofit leadership, and community advocacy, having worked and volunteered with organizations such as The Arc of Montgomery and Best Buddies Maryland. "Bello Machre's mission of providing loving care and a sense of family resonates deeply with me," she expresses. "I'm excited to contribute to this impactful work."

"Dr. Jones Taylor's dedication to advocacy and community aligns perfectly with our mission at Bello Machre," says Dr. Robert Ireland, President & CEO of Bello Machre. "Her expertise and passion will help us expand opportunities for people with developmental disabilities, ensuring they experience a lifetime of loving care and meaningful lives. We are honored to welcome Dr. Jones Taylor to our Board of Directors."

Bello Machre looks forward to Dr. Jones Taylor's leadership in shaping the organization's future and expanding its reach.

About Bello Machre: Founded in 1972, Bello Machre is a nonprofit serving Anne Arundel and Carroll Counties, MD, providing lifelong care and support for individuals with developmental disabilities. With 50 community homes across Central Maryland, it offers Residential/Group Home Services, Personal Supports, and Respite Care. Its Meaningful Day Services include day programs and employment assistance, while the Ray of Hope Program helps with specialized expenses. Bello Machre empowers people with developmental disabilities to live full, meaningful lives.

Media Contact;
Michelle Meek
[email protected]
773.220.3120

Bello Machre Contact: 
Hunter Jackson
Marketing Director
[email protected]
443.702.3078

SOURCE Bello Machre


These press releases may also interest you

at 20:15
From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally developed innovative candidates, including the...

at 19:30
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, will present new data at the American Association for Cancer...

at 19:11
Unifor Local 922 members at Nutrien have voted in favour of a new collective agreement that delivers wage increases and benefit improvements. "Potash miners help extract a key strategic resource for Canadians," said Unifor National President Lana...

at 19:05
Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications, has announced that it has entered into an agreement with the Royal Perth...

at 19:05
New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for novel combinations, across stages and settings of...

at 19:05
Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a collaboration aimed at developing an automated,...



News published on and distributed by: